Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1568-2020Class II

Encina HA Femoral Stem, Size 11 Coxa Vara Collared, REF 100-30-011, Ti6AI4V Allow with HA Coating, For use...

Signature Orthopaedics Europe Ltd / initiated 2019-10-09 / Open, Classified / root cause: labeling and UDI

Signature Orthopaedics Europe Ltd began a recall of Encina HA Femoral Stem, Size 11 Coxa Vara Collared, REF 100-30-011, Ti6AI4V Allow with HA Coating, For use with Stinson Orthopedics Inc. Total Hip Replacement... on . FDA classified it as Class II and gives the reason as "The firm has identified that packaging containing components of the hip replacement range are mislabeled. This could result in the product intended to be used for a procedure not included in the packaging resulting in a...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1568-2020
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Signature Orthopaedics Europe Ltd
Product
Encina HA Femoral Stem, Size 11 Coxa Vara Collared, REF 100-30-011, Ti6AI4V Allow with HA Coating, For use with Stinson Orthopedics Inc. Total Hip Replacement System Only, CEMENTLESS, UDI: (01) 00841176102934
Product code
MEH Prosthesis, Hip, Semi-Constrained, Uncemented, Metal / Polymer, Non-Porous, Calcium Phosphate
Reason for recall
The firm has identified that packaging containing components of the hip replacement range are mislabeled. This could result in the product intended to be used for a procedure not included in the packaging resulting in a surgical delay.
Root cause tag
labeling and UDI
FDA root cause
Labeling Change Control
Action
On October 9, 2019, the firm sent an "URGENT MEDICAL DEVICE RECALL" Letter via email to affected customers. In addition to informing the customers about the recall, the firm asked customers to take the following action: 1. Immediately examine your inventory and quarantine product subject to recall. In addition, if you have further distributed this product, please identify your customers and notify them at once of this product recall by forwarding this letter. 2. Please complete the attached Customer Acknowledgement Form and email it to us so that we may arrange for your stock to be recovered and replacement stock, or a credit note, issued. Please complete the Customer Acknowledgement Form even if you have no stock which is subject to recall, as we require this information to reconcile this process. Please complete this action within 2 weeks of the date on this letter to ensure the correction is implemented expeditiously. 3. This recall should be carried out to the hospital level. 4. For further information, please contact, christian Wight, [email protected]
Quantity in commerce
5 components
Distribution
US: California
Product codes and lots
Lot # 7DD49-1

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1568-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1568-2020Class IIOngoingVoluntary: Firm initiated